检测胆汁和血浆中的微小RNA对胰腺导管腺癌诊断的价值 - Suppr | 超能文献

相似文献

1

Usefulness of Measuring microRNAs in Bile and Plasma for Pancreatic Ductal Adenocarcinoma Diagnosis.检测胆汁和血浆中的微小RNA对胰腺导管腺癌诊断的价值

Am J Gastroenterol. 2015 May;110(5):768-9. doi: 10.1038/ajg.2015.77.

2

Response to Le Large et al.

Am J Gastroenterol. 2015 May;110(5):769-70. doi: 10.1038/ajg.2015.82.

3

A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.一项基于血浆和胆汁中特定微小RNA差异表达开发胰腺导管腺癌诊断测试的初步研究。

Am J Gastroenterol. 2014 Dec;109(12):1942-52. doi: 10.1038/ajg.2014.331. Epub 2014 Oct 28.

4

No miR quirk: dysregulation of microRNAs in pancreatic ductal adenocarcinoma.

Microrna. 2012;1(1):49-58. doi: 10.2174/2211536611201010049.

5

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma.MiR-21、miR-34a、miR-198和miR-217作为慢性胰腺炎和胰腺导管腺癌的诊断及预后生物标志物。

Diagn Pathol. 2015 Apr 24;10:38. doi: 10.1186/s13000-015-0272-6.

6

MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma.与胰腺腺癌和壶腹腺癌相关的 microRNA 表达谱。

Mod Pathol. 2012 Dec;25(12):1609-22. doi: 10.1038/modpathol.2012.122. Epub 2012 Aug 10.

7

The role of miR-10b in metastatic pancreatic ductal adenocarcinoma.miR-10b在转移性胰腺导管腺癌中的作用。

Surgery. 2012 Nov;152(5):936-8; author reply 938. doi: 10.1016/j.surg.2012.03.021. Epub 2012 Jun 6.

8

MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor.微小 RNA-132 在胰腺导管腺癌中发挥独立的预后作用，并作为一种肿瘤抑制因子。

Technol Cancer Res Treat. 2019 Jan 1;18:1533033818824314. doi: 10.1177/1533033818824314.

9

Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature.循环 miRNA 在胰腺导管腺癌的诊断、预后、筛查和监测治疗中的临床价值——文献综述。

Int J Mol Sci. 2023 Mar 7;24(6):5113. doi: 10.3390/ijms24065113.

10

Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.通过加权基因共表达网络分析鉴定胰腺导管腺癌的候选 miRNA 生物标志物

Cell Oncol (Dordr). 2017 Apr;40(2):181-192. doi: 10.1007/s13402-017-0315-y. Epub 2017 Feb 15.

引用本文的文献

1

Response to Le Large et al.

Am J Gastroenterol. 2015 May;110(5):769-70. doi: 10.1038/ajg.2015.82.

本文引用的文献

1

A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile.一项基于血浆和胆汁中特定微小RNA差异表达开发胰腺导管腺癌诊断测试的初步研究。

Am J Gastroenterol. 2014 Dec;109(12):1942-52. doi: 10.1038/ajg.2014.331. Epub 2014 Oct 28.

2

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms.好的、坏的和丑的：miR-101、miR-21 和 miR-155 在胰腺导管内乳头状黏液性肿瘤中的故事。

Ann Oncol. 2013 Mar;24(3):734-41. doi: 10.1093/annonc/mds513. Epub 2012 Nov 8.

3

Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue.